View Future GrowthHuikwang 과거 순이익 실적과거 기준 점검 1/6Huikwang의 수입은 연평균 -39.6%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 1.7% 감소했습니다. 매출은 연평균 9.2%의 비율로 감소해 왔습니다. Huikwang의 자기자본이익률은 0.8%이고 순이익률은 1.3%입니다.핵심 정보-39.57%순이익 성장률-39.78%주당순이익(EPS) 성장률Chemicals 산업 성장률7.89%매출 성장률-9.22%자기자본이익률0.80%순이익률1.32%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 14First quarter 2026 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2025)First quarter 2026 results: EPS: NT$0.36 (down from NT$0.41 in 1Q 2025). Revenue: NT$461.5m (up 6.0% from 1Q 2025). Net income: NT$31.4m (down 11% from 1Q 2025). Profit margin: 6.8% (down from 8.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 11Full year 2025 earnings released: EPS: NT$0.27 (vs NT$1.07 in FY 2024)Full year 2025 results: EPS: NT$0.27 (down from NT$1.07 in FY 2024). Revenue: NT$1.42b (down 4.1% from FY 2024). Net income: NT$23.0m (down 75% from FY 2024). Profit margin: 1.6% (down from 6.2% in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 08Third quarter 2025 earnings released: EPS: NT$0.14 (vs NT$0.059 in 3Q 2024)Third quarter 2025 results: EPS: NT$0.14 (up from NT$0.059 in 3Q 2024). Revenue: NT$256.9m (down 13% from 3Q 2024). Net income: NT$12.0m (up 137% from 3Q 2024). Profit margin: 4.7% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2025 earnings released: NT$0.28 loss per share (vs NT$0.46 profit in 2Q 2024)Second quarter 2025 results: NT$0.28 loss per share (down from NT$0.46 profit in 2Q 2024). Revenue: NT$547.4m (up 19% from 2Q 2024). Net loss: NT$24.4m (down 162% from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.Reported Earnings • May 07First quarter 2025 earnings released: EPS: NT$0.41 (vs NT$0.49 in 1Q 2024)First quarter 2025 results: EPS: NT$0.41 (down from NT$0.49 in 1Q 2024). Revenue: NT$435.4m (flat on 1Q 2024). Net income: NT$35.3m (down 18% from 1Q 2024). Profit margin: 8.1% (down from 9.9% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공시 • Apr 29Huikwang Corporation to Report Q1, 2025 Results on May 06, 2025Huikwang Corporation announced that they will report Q1, 2025 results on May 06, 2025모든 업데이트 보기Recent updatesReported Earnings • May 14First quarter 2026 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2025)First quarter 2026 results: EPS: NT$0.36 (down from NT$0.41 in 1Q 2025). Revenue: NT$461.5m (up 6.0% from 1Q 2025). Net income: NT$31.4m (down 11% from 1Q 2025). Profit margin: 6.8% (down from 8.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 11Full year 2025 earnings released: EPS: NT$0.27 (vs NT$1.07 in FY 2024)Full year 2025 results: EPS: NT$0.27 (down from NT$1.07 in FY 2024). Revenue: NT$1.42b (down 4.1% from FY 2024). Net income: NT$23.0m (down 75% from FY 2024). Profit margin: 1.6% (down from 6.2% in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.공시 • Mar 10Huikwang Corporation, Annual General Meeting, Jun 25, 2026Huikwang Corporation, Annual General Meeting, Jun 25, 2026. Location: 3 floor no,259, sec.1 ma chia rd., madou district, tainan city TaiwanReported Earnings • Nov 08Third quarter 2025 earnings released: EPS: NT$0.14 (vs NT$0.059 in 3Q 2024)Third quarter 2025 results: EPS: NT$0.14 (up from NT$0.059 in 3Q 2024). Revenue: NT$256.9m (down 13% from 3Q 2024). Net income: NT$12.0m (up 137% from 3Q 2024). Profit margin: 4.7% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2025 earnings released: NT$0.28 loss per share (vs NT$0.46 profit in 2Q 2024)Second quarter 2025 results: NT$0.28 loss per share (down from NT$0.46 profit in 2Q 2024). Revenue: NT$547.4m (up 19% from 2Q 2024). Net loss: NT$24.4m (down 162% from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.Declared Dividend • Jun 26Dividend of NT$1.00 announcedDividend of NT$1.00 is the same as last year. Ex-date: 9th July 2025 Payment date: 1st August 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio). However, it is covered by cash flows (80% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control. However, EPS has declined by 20% over the last 5 years so the company would need to reverse this trend.Reported Earnings • May 07First quarter 2025 earnings released: EPS: NT$0.41 (vs NT$0.49 in 1Q 2024)First quarter 2025 results: EPS: NT$0.41 (down from NT$0.49 in 1Q 2024). Revenue: NT$435.4m (flat on 1Q 2024). Net income: NT$35.3m (down 18% from 1Q 2024). Profit margin: 8.1% (down from 9.9% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.공시 • Apr 29Huikwang Corporation to Report Q1, 2025 Results on May 06, 2025Huikwang Corporation announced that they will report Q1, 2025 results on May 06, 2025Reported Earnings • Mar 18Full year 2024 earnings released: EPS: NT$1.07 (vs NT$1.05 in FY 2023)Full year 2024 results: EPS: NT$1.07 (up from NT$1.05 in FY 2023). Revenue: NT$1.48b (down 2.8% from FY 2023). Net income: NT$92.6m (up 1.8% from FY 2023). Profit margin: 6.2% (up from 6.0% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.공시 • Mar 14Huikwang Corporation, Annual General Meeting, Jun 24, 2025Huikwang Corporation, Annual General Meeting, Jun 24, 2025. Location: 3 floor no,259, sec.1 ma chia rd., madou district, tainan city Taiwan공시 • Mar 06Huikwang Corporation to Report Q4, 2024 Results on Mar 13, 2025Huikwang Corporation announced that they will report Q4, 2024 results on Mar 13, 2025New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.8% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.6% net profit margin). Market cap is less than US$100m (NT$2.60b market cap, or US$79.1m).공시 • Nov 05Huikwang Corporation to Report Q3, 2024 Results on Nov 12, 2024Huikwang Corporation announced that they will report Q3, 2024 results on Nov 12, 2024Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: NT$0.46 (vs NT$0.39 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.46 (up from NT$0.39 in 2Q 2023). Revenue: NT$459.7m (up 13% from 2Q 2023). Net income: NT$39.6m (up 16% from 2Q 2023). Profit margin: 8.6% (up from 8.4% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Declared Dividend • Jun 27Dividend reduced to NT$1.00Dividend of NT$1.00 is 63% lower than last year. Ex-date: 9th July 2024 Payment date: 31st July 2024 Dividend yield will be 3.0%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (89% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share declined by 16% over the last 5 years, which if continued should see the payout ratio increase to a potentially unsustainable range.Reported Earnings • May 11First quarter 2024 earnings released: EPS: NT$0.50 (vs NT$0.43 in 1Q 2023)First quarter 2024 results: EPS: NT$0.50 (up from NT$0.43 in 1Q 2023). Revenue: NT$432.8m (down 7.9% from 1Q 2023). Net income: NT$42.8m (up 17% from 1Q 2023). Profit margin: 9.9% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.공시 • May 01Huikwang Corporation to Report Q1, 2024 Results on May 07, 2024Huikwang Corporation announced that they will report Q1, 2024 results at 9:00 AM, Taipei Standard Time on May 07, 2024Reported Earnings • Mar 21Full year 2023 earnings released: EPS: NT$1.05 (vs NT$3.66 in FY 2022)Full year 2023 results: EPS: NT$1.05 (down from NT$3.66 in FY 2022). Revenue: NT$1.53b (down 39% from FY 2022). Net income: NT$90.9m (down 71% from FY 2022). Profit margin: 6.0% (down from 13% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.공시 • Mar 16Huikwang Corporation, Annual General Meeting, Jun 24, 2024Huikwang Corporation, Annual General Meeting, Jun 24, 2024.Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 2.6%. The fair value is estimated to be NT$42.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years, while earnings per share has been flat.New Risk • Nov 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.9% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (218% payout ratio). Profit margins are more than 30% lower than last year (6.9% net profit margin). Market cap is less than US$100m (NT$2.96b market cap, or US$93.1m).Buying Opportunity • Oct 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.6%. The fair value is estimated to be NT$42.09, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.Buying Opportunity • Oct 04Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10.0%. The fair value is estimated to be NT$42.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.Buying Opportunity • Aug 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be NT$42.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: NT$0.39 (vs NT$1.24 in 2Q 2022)Second quarter 2023 results: EPS: NT$0.39 (down from NT$1.24 in 2Q 2022). Revenue: NT$406.9m (down 49% from 2Q 2022). Net income: NT$34.1m (down 68% from 2Q 2022). Profit margin: 8.4% (down from 14% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.New Risk • Jul 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$3.07b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (NT$3.07b market cap, or US$98.1m).Upcoming Dividend • Jul 13Upcoming dividend of NT$2.69 per share at 7.2% yieldEligible shareholders must have bought the stock before 20 July 2023. Payment date: 10 August 2023. Payout ratio is on the higher end at 89%, however this is supported by cash flows. Trailing yield: 7.2%. Within top quartile of Taiwanese dividend payers (5.5%). Higher than average of industry peers (3.8%).공시 • Jul 06Huikwang Corporation Announces Cash Dividend, Payable on August 10, 2023Huikwang Corporation announced a cash dividend of TWD 2.68509558 per share or TWD 232,365,121. Ex-rights (ex-dividend) trading date is July 20, 2023. Ex-rights (ex-dividend) record date is July 26, 2023. The payment date of cash dividend distribution is August 10, 2023.공시 • Jun 29+ 2 more updatesHuikwang Corporation Announces Board AppointmentsHuikwang Corporation announced that title and name of the previous position holder: Director Chen Guan Hua, Director Chen Rong Dong, Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Director Guo Yu Zheng, Independent Director Cai Ming Zhi, Independent Director Cai Ming Tang, Independent Director Zhang Bo Ren. Resume of the previous position holder: Director Chen Guan Hua?GChairman and General Manager of Huikwang Corp., Director Chen Rong Dong?GChairman of Huikwang Investment Corp., Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Deputy General Manager of Huikwang Corp., Director Guo Yu Zheng?GDeputy General Manager of Finance Department at SUN YAD CONSTRUCTION CO., LTD, Independent Director Cai Ming Zhi?GDeputy General Manager of TA YIH INDUSTRIAL CO.,LTD Independent Director Cai Ming Tang?GChief Executive Officer of TOP Management Technology Co.,Ltd, Independent Director Zhang Bo Ren?GFounder of i-Full Care Management Consultant Ltd. Title and name of the new position holder: Director Chen Guan Hua, Director Chen Rong Dong, Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Independent Director Cai Ming Zhi, Independent Director Cai Ming Tang, Independent Director Zhang Bo Ren, Independent Director Lin Hong Yuan. Resume of the new position holder: Director Chen Guan Hua?GChairman and General Manager of Huikwang Corp., Director Chen Rong Dong?GChairman of Huikwang Investment Corp., Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Deputy General Manager of Huikwang Corp. Independent Director Cai Ming Zhi?GIndependent Director of YING HAN TECHNOLOGY CO., LTD., Independent Director Cai Ming Tang?GChief Executive Officer of TOP Management Technology Co.,Ltd, Independent Director Zhang Bo Ren?GFounder of i-Full CareManagement Consultant Ltd., Independent Director Lin Hong Yuan?GPracticing Accountant at Xincheng Accounting Firm. Effective date of the new appointment is June 28, 2023.Reported Earnings • Apr 01Full year 2022 earnings released: EPS: NT$3.66 (vs NT$3.85 in FY 2021)Full year 2022 results: EPS: NT$3.66 (down from NT$3.85 in FY 2021). Revenue: NT$2.49b (up 19% from FY 2021). Net income: NT$314.5m (down 4.4% from FY 2021). Profit margin: 13% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 13% per year.Buying Opportunity • Dec 06Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be NT$48.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 16%.Reported Earnings • Nov 10Third quarter 2022 earnings released: EPS: NT$1.40 (vs NT$0.39 in 3Q 2021)Third quarter 2022 results: EPS: NT$1.40 (up from NT$0.39 in 3Q 2021). Revenue: NT$798.5m (up 63% from 3Q 2021). Net income: NT$120.9m (up 263% from 3Q 2021). Profit margin: 15% (up from 6.8% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to NT$35.20, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 38% over the past three years.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to NT$38.00, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 14x in the Chemicals industry in Taiwan. Total returns to shareholders of 54% over the past three years.Buying Opportunity • Sep 26Now 22% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be NT$58.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%.Upcoming Dividend • Sep 20Upcoming dividend of NT$2.99 per shareEligible shareholders must have bought the stock before 27 September 2022. Payment date: 21 October 2022. Payout ratio is on the higher end at 95% but the company is not cash flow positive. Trailing yield: 6.2%. Lower than top quartile of Taiwanese dividend payers (6.7%). Lower than average of industry peers (8.1%).Buying Opportunity • Aug 20Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$57.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%.Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: NT$1.24 (vs NT$2.34 in 2Q 2021)Second quarter 2022 results: EPS: NT$1.24 (down from NT$2.34 in 2Q 2021). Revenue: NT$793.3m (up 41% from 2Q 2021). Net income: NT$106.9m (down 47% from 2Q 2021). Profit margin: 14% (down from 36% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.Reported Earnings • May 16First quarter 2022 earnings released: EPS: NT$1.06 (vs NT$0.67 in 1Q 2021)First quarter 2022 results: EPS: NT$1.06 (up from NT$0.67 in 1Q 2021). Revenue: NT$632.7m (up 20% from 1Q 2021). Net income: NT$91.0m (up 60% from 1Q 2021). Profit margin: 14% (up from 11% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 18% per year.Buying Opportunity • May 12Now 23% undervaluedOver the last 90 days, the stock is up 35%. The fair value is estimated to be NT$58.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.2% over the last 3 years. Earnings per share has grown by 10%.Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$49.15, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 100% over the past three years.Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improved over the past weekAfter last week's 20% share price gain to NT$53.90, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 125% over the past three years.공시 • Apr 02Huikwang Corporation, Annual General Meeting, Jun 22, 2022Huikwang Corporation, Annual General Meeting, Jun 22, 2022.Reported Earnings • Mar 31Full year 2021 earnings released: EPS: NT$3.85 (vs NT$2.22 in FY 2020)Full year 2021 results: EPS: NT$3.85 (up from NT$2.22 in FY 2020). Revenue: NT$2.09b (up 14% from FY 2020). Net income: NT$329.1m (up 74% from FY 2020). Profit margin: 16% (up from 10% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improved over the past weekAfter last week's 26% share price gain to NT$44.30, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 84% over the past three years.Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS NT$0.39 (vs NT$0.39 in 3Q 2020)The company reported a mediocre third quarter result with weaker profit margins, although earnings were flat and revenues improved. Third quarter 2021 results: Revenue: NT$488.8m (up 26% from 3Q 2020). Net income: NT$33.3m (flat on 3Q 2020). Profit margin: 6.8% (down from 8.6% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year.Valuation Update With 7 Day Price Move • Oct 19Investor sentiment improved over the past weekAfter last week's 22% share price gain to NT$39.30, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 81% over the past three years.Upcoming Dividend • Aug 19Upcoming dividend of NT$1.59 per shareEligible shareholders must have bought the stock before 26 August 2021. Payment date: 17 September 2021. Trailing yield: 5.2%. Within top quartile of Taiwanese dividend payers (5.2%). Higher than average of industry peers (2.9%).Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS NT$2.34 (vs NT$0.71 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$562.9m (up 3.7% from 2Q 2020). Net income: NT$200.5m (up 230% from 2Q 2020). Profit margin: 36% (up from 11% in 2Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 3% per year.Reported Earnings • May 14First quarter 2021 earnings released: EPS NT$0.67 (vs NT$1.05 in 1Q 2020)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$525.5m (down 13% from 1Q 2020). Net income: NT$57.0m (down 36% from 1Q 2020). Profit margin: 11% (down from 15% in 1Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.분석 기사 • Mar 31Huikwang (GTSM:6508) Might Have The Makings Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • Mar 27Full year 2020 earnings released: EPS NT$2.22 (vs NT$2.67 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$1.84b (down 12% from FY 2019). Net income: NT$189.2m (down 16% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Mar 10New 90-day high: NT$31.00The company is up 1.0% from its price of NT$30.65 on 10 December 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.분석 기사 • Mar 10Huikwang Corporation (GTSM:6508) Is Yielding 5.9% - But Is It A Buy?Dividend paying stocks like Huikwang Corporation ( GTSM:6508 ) tend to be popular with investors, and for good reason...분석 기사 • Feb 16Huikwang (GTSM:6508) Could Easily Take On More DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Jan 27Is Huikwang Corporation's (GTSM:6508) Latest Stock Performance Being Led By Its Strong Fundamentals?Most readers would already know that Huikwang's (GTSM:6508) stock increased by 3.3% over the past three months. Given...분석 기사 • Jan 06Shareholders Of Huikwang (GTSM:6508) Must Be Happy With Their 65% ReturnWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...분석 기사 • Dec 15Will the Promising Trends At Huikwang (GTSM:6508) Continue?What are the early trends we should look for to identify a stock that could multiply in value over the long term...Is New 90 Day High Low • Dec 09New 90-day high: NT$30.90The company is up 4.0% from its price of NT$29.60 on 11 September 2020. The Taiwanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.분석 기사 • Nov 27Is Huikwang Corporation (GTSM:6508) A Smart Choice For Dividend Investors?Could Huikwang Corporation (GTSM:6508) be an attractive dividend share to own for the long haul? Investors are often...Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS NT$0.39The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$387.5m (down 25% from 3Q 2019). Net income: NT$33.3m (down 44% from 3Q 2019). Profit margin: 8.6% (down from 11% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.매출 및 비용 세부 내역Huikwang가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TPEX:6508 매출, 비용 및 순이익 (TWD Millions)날짜매출순이익일반관리비연구개발비31 Mar 261,449192363431 Dec 251,423232293330 Sep 251,459262163330 Jun 251,574212093531 Mar 251,486852323731 Dec 241,484932313730 Sep 241,495692213830 Jun 241,5431032233731 Mar 241,490972193731 Dec 231,527912193830 Sep 231,5631072303730 Jun 231,9421872613831 Mar 232,3282602803631 Dec 222,4913142813630 Sep 222,7363572763730 Jun 222,4272692403631 Mar 222,1963632563631 Dec 212,0893292713530 Sep 211,8842972633530 Jun 211,7832972553431 Mar 211,7621572163531 Dec 201,8371892093730 Sep 201,8742032153830 Jun 202,0042292324031 Mar 202,0832482494231 Dec 192,0772262444130 Sep 192,2182442564030 Jun 192,1662212513931 Mar 192,2042232613631 Dec 182,1691822573530 Sep 182,0681602423430 Jun 182,1221722423331 Mar 182,0161372343331 Dec 172,0731372492830 Sep 172,1551552722330 Jun 172,2121392941831 Mar 172,3771443161331 Dec 162,2991693151330 Sep 162,2661473071430 Jun 162,1931602871431 Mar 162,1841692671431 Dec 152,3241652711430 Sep 152,4741912881330 Jun 152,53319827514양질의 수익: 6508는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 6508의 현재 순 이익률 (1.3%)은 지난해 (5.7%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 6508의 수익은 지난 5년 동안 연평균 39.6% 감소했습니다.성장 가속화: 6508은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: 6508은 지난 1년 동안 수익이 감소(-77.5%)하여 Chemicals 업계 평균(-7.2%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: 6508의 자본 수익률(0.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 23:23종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Huikwang Corporation는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Xuanyi YangCapital Securities CorporationHengyu FuMasterlink Securities Investment Advisory
Reported Earnings • May 14First quarter 2026 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2025)First quarter 2026 results: EPS: NT$0.36 (down from NT$0.41 in 1Q 2025). Revenue: NT$461.5m (up 6.0% from 1Q 2025). Net income: NT$31.4m (down 11% from 1Q 2025). Profit margin: 6.8% (down from 8.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 11Full year 2025 earnings released: EPS: NT$0.27 (vs NT$1.07 in FY 2024)Full year 2025 results: EPS: NT$0.27 (down from NT$1.07 in FY 2024). Revenue: NT$1.42b (down 4.1% from FY 2024). Net income: NT$23.0m (down 75% from FY 2024). Profit margin: 1.6% (down from 6.2% in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 08Third quarter 2025 earnings released: EPS: NT$0.14 (vs NT$0.059 in 3Q 2024)Third quarter 2025 results: EPS: NT$0.14 (up from NT$0.059 in 3Q 2024). Revenue: NT$256.9m (down 13% from 3Q 2024). Net income: NT$12.0m (up 137% from 3Q 2024). Profit margin: 4.7% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2025 earnings released: NT$0.28 loss per share (vs NT$0.46 profit in 2Q 2024)Second quarter 2025 results: NT$0.28 loss per share (down from NT$0.46 profit in 2Q 2024). Revenue: NT$547.4m (up 19% from 2Q 2024). Net loss: NT$24.4m (down 162% from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 07First quarter 2025 earnings released: EPS: NT$0.41 (vs NT$0.49 in 1Q 2024)First quarter 2025 results: EPS: NT$0.41 (down from NT$0.49 in 1Q 2024). Revenue: NT$435.4m (flat on 1Q 2024). Net income: NT$35.3m (down 18% from 1Q 2024). Profit margin: 8.1% (down from 9.9% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공시 • Apr 29Huikwang Corporation to Report Q1, 2025 Results on May 06, 2025Huikwang Corporation announced that they will report Q1, 2025 results on May 06, 2025
Reported Earnings • May 14First quarter 2026 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2025)First quarter 2026 results: EPS: NT$0.36 (down from NT$0.41 in 1Q 2025). Revenue: NT$461.5m (up 6.0% from 1Q 2025). Net income: NT$31.4m (down 11% from 1Q 2025). Profit margin: 6.8% (down from 8.1% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 11Full year 2025 earnings released: EPS: NT$0.27 (vs NT$1.07 in FY 2024)Full year 2025 results: EPS: NT$0.27 (down from NT$1.07 in FY 2024). Revenue: NT$1.42b (down 4.1% from FY 2024). Net income: NT$23.0m (down 75% from FY 2024). Profit margin: 1.6% (down from 6.2% in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
공시 • Mar 10Huikwang Corporation, Annual General Meeting, Jun 25, 2026Huikwang Corporation, Annual General Meeting, Jun 25, 2026. Location: 3 floor no,259, sec.1 ma chia rd., madou district, tainan city Taiwan
Reported Earnings • Nov 08Third quarter 2025 earnings released: EPS: NT$0.14 (vs NT$0.059 in 3Q 2024)Third quarter 2025 results: EPS: NT$0.14 (up from NT$0.059 in 3Q 2024). Revenue: NT$256.9m (down 13% from 3Q 2024). Net income: NT$12.0m (up 137% from 3Q 2024). Profit margin: 4.7% (up from 1.7% in 3Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2025 earnings released: NT$0.28 loss per share (vs NT$0.46 profit in 2Q 2024)Second quarter 2025 results: NT$0.28 loss per share (down from NT$0.46 profit in 2Q 2024). Revenue: NT$547.4m (up 19% from 2Q 2024). Net loss: NT$24.4m (down 162% from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 45 percentage points per year, which is a significant difference in performance.
Declared Dividend • Jun 26Dividend of NT$1.00 announcedDividend of NT$1.00 is the same as last year. Ex-date: 9th July 2025 Payment date: 1st August 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio). However, it is covered by cash flows (80% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control. However, EPS has declined by 20% over the last 5 years so the company would need to reverse this trend.
Reported Earnings • May 07First quarter 2025 earnings released: EPS: NT$0.41 (vs NT$0.49 in 1Q 2024)First quarter 2025 results: EPS: NT$0.41 (down from NT$0.49 in 1Q 2024). Revenue: NT$435.4m (flat on 1Q 2024). Net income: NT$35.3m (down 18% from 1Q 2024). Profit margin: 8.1% (down from 9.9% in 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
공시 • Apr 29Huikwang Corporation to Report Q1, 2025 Results on May 06, 2025Huikwang Corporation announced that they will report Q1, 2025 results on May 06, 2025
Reported Earnings • Mar 18Full year 2024 earnings released: EPS: NT$1.07 (vs NT$1.05 in FY 2023)Full year 2024 results: EPS: NT$1.07 (up from NT$1.05 in FY 2023). Revenue: NT$1.48b (down 2.8% from FY 2023). Net income: NT$92.6m (up 1.8% from FY 2023). Profit margin: 6.2% (up from 6.0% in FY 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
공시 • Mar 14Huikwang Corporation, Annual General Meeting, Jun 24, 2025Huikwang Corporation, Annual General Meeting, Jun 24, 2025. Location: 3 floor no,259, sec.1 ma chia rd., madou district, tainan city Taiwan
공시 • Mar 06Huikwang Corporation to Report Q4, 2024 Results on Mar 13, 2025Huikwang Corporation announced that they will report Q4, 2024 results on Mar 13, 2025
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.8% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (6.6% net profit margin). Market cap is less than US$100m (NT$2.60b market cap, or US$79.1m).
공시 • Nov 05Huikwang Corporation to Report Q3, 2024 Results on Nov 12, 2024Huikwang Corporation announced that they will report Q3, 2024 results on Nov 12, 2024
Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: NT$0.46 (vs NT$0.39 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.46 (up from NT$0.39 in 2Q 2023). Revenue: NT$459.7m (up 13% from 2Q 2023). Net income: NT$39.6m (up 16% from 2Q 2023). Profit margin: 8.6% (up from 8.4% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Declared Dividend • Jun 27Dividend reduced to NT$1.00Dividend of NT$1.00 is 63% lower than last year. Ex-date: 9th July 2024 Payment date: 31st July 2024 Dividend yield will be 3.0%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (89% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share declined by 16% over the last 5 years, which if continued should see the payout ratio increase to a potentially unsustainable range.
Reported Earnings • May 11First quarter 2024 earnings released: EPS: NT$0.50 (vs NT$0.43 in 1Q 2023)First quarter 2024 results: EPS: NT$0.50 (up from NT$0.43 in 1Q 2023). Revenue: NT$432.8m (down 7.9% from 1Q 2023). Net income: NT$42.8m (up 17% from 1Q 2023). Profit margin: 9.9% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
공시 • May 01Huikwang Corporation to Report Q1, 2024 Results on May 07, 2024Huikwang Corporation announced that they will report Q1, 2024 results at 9:00 AM, Taipei Standard Time on May 07, 2024
Reported Earnings • Mar 21Full year 2023 earnings released: EPS: NT$1.05 (vs NT$3.66 in FY 2022)Full year 2023 results: EPS: NT$1.05 (down from NT$3.66 in FY 2022). Revenue: NT$1.53b (down 39% from FY 2022). Net income: NT$90.9m (down 71% from FY 2022). Profit margin: 6.0% (down from 13% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
공시 • Mar 16Huikwang Corporation, Annual General Meeting, Jun 24, 2024Huikwang Corporation, Annual General Meeting, Jun 24, 2024.
Buying Opportunity • Dec 13Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 2.6%. The fair value is estimated to be NT$42.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years, while earnings per share has been flat.
New Risk • Nov 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.9% Last year net profit margin: 13% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (218% payout ratio). Profit margins are more than 30% lower than last year (6.9% net profit margin). Market cap is less than US$100m (NT$2.96b market cap, or US$93.1m).
Buying Opportunity • Oct 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 7.6%. The fair value is estimated to be NT$42.09, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.
Buying Opportunity • Oct 04Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10.0%. The fair value is estimated to be NT$42.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.
Buying Opportunity • Aug 14Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be NT$42.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.4% over the last 3 years. Earnings per share has grown by 9.1%.
Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: NT$0.39 (vs NT$1.24 in 2Q 2022)Second quarter 2023 results: EPS: NT$0.39 (down from NT$1.24 in 2Q 2022). Revenue: NT$406.9m (down 49% from 2Q 2022). Net income: NT$34.1m (down 68% from 2Q 2022). Profit margin: 8.4% (down from 14% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
New Risk • Jul 21New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$3.07b (US$98.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (NT$3.07b market cap, or US$98.1m).
Upcoming Dividend • Jul 13Upcoming dividend of NT$2.69 per share at 7.2% yieldEligible shareholders must have bought the stock before 20 July 2023. Payment date: 10 August 2023. Payout ratio is on the higher end at 89%, however this is supported by cash flows. Trailing yield: 7.2%. Within top quartile of Taiwanese dividend payers (5.5%). Higher than average of industry peers (3.8%).
공시 • Jul 06Huikwang Corporation Announces Cash Dividend, Payable on August 10, 2023Huikwang Corporation announced a cash dividend of TWD 2.68509558 per share or TWD 232,365,121. Ex-rights (ex-dividend) trading date is July 20, 2023. Ex-rights (ex-dividend) record date is July 26, 2023. The payment date of cash dividend distribution is August 10, 2023.
공시 • Jun 29+ 2 more updatesHuikwang Corporation Announces Board AppointmentsHuikwang Corporation announced that title and name of the previous position holder: Director Chen Guan Hua, Director Chen Rong Dong, Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Director Guo Yu Zheng, Independent Director Cai Ming Zhi, Independent Director Cai Ming Tang, Independent Director Zhang Bo Ren. Resume of the previous position holder: Director Chen Guan Hua?GChairman and General Manager of Huikwang Corp., Director Chen Rong Dong?GChairman of Huikwang Investment Corp., Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Deputy General Manager of Huikwang Corp., Director Guo Yu Zheng?GDeputy General Manager of Finance Department at SUN YAD CONSTRUCTION CO., LTD, Independent Director Cai Ming Zhi?GDeputy General Manager of TA YIH INDUSTRIAL CO.,LTD Independent Director Cai Ming Tang?GChief Executive Officer of TOP Management Technology Co.,Ltd, Independent Director Zhang Bo Ren?GFounder of i-Full Care Management Consultant Ltd. Title and name of the new position holder: Director Chen Guan Hua, Director Chen Rong Dong, Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Independent Director Cai Ming Zhi, Independent Director Cai Ming Tang, Independent Director Zhang Bo Ren, Independent Director Lin Hong Yuan. Resume of the new position holder: Director Chen Guan Hua?GChairman and General Manager of Huikwang Corp., Director Chen Rong Dong?GChairman of Huikwang Investment Corp., Director Tang Qiu Ying(Representative of Huikwang Investment Corp.), Deputy General Manager of Huikwang Corp. Independent Director Cai Ming Zhi?GIndependent Director of YING HAN TECHNOLOGY CO., LTD., Independent Director Cai Ming Tang?GChief Executive Officer of TOP Management Technology Co.,Ltd, Independent Director Zhang Bo Ren?GFounder of i-Full CareManagement Consultant Ltd., Independent Director Lin Hong Yuan?GPracticing Accountant at Xincheng Accounting Firm. Effective date of the new appointment is June 28, 2023.
Reported Earnings • Apr 01Full year 2022 earnings released: EPS: NT$3.66 (vs NT$3.85 in FY 2021)Full year 2022 results: EPS: NT$3.66 (down from NT$3.85 in FY 2021). Revenue: NT$2.49b (up 19% from FY 2021). Net income: NT$314.5m (down 4.4% from FY 2021). Profit margin: 13% (down from 16% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 13% per year.
Buying Opportunity • Dec 06Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 20%. The fair value is estimated to be NT$48.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 16%.
Reported Earnings • Nov 10Third quarter 2022 earnings released: EPS: NT$1.40 (vs NT$0.39 in 3Q 2021)Third quarter 2022 results: EPS: NT$1.40 (up from NT$0.39 in 3Q 2021). Revenue: NT$798.5m (up 63% from 3Q 2021). Net income: NT$120.9m (up 263% from 3Q 2021). Profit margin: 15% (up from 6.8% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to NT$35.20, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 38% over the past three years.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to NT$38.00, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 14x in the Chemicals industry in Taiwan. Total returns to shareholders of 54% over the past three years.
Buying Opportunity • Sep 26Now 22% undervaluedOver the last 90 days, the stock is up 17%. The fair value is estimated to be NT$58.25, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%.
Upcoming Dividend • Sep 20Upcoming dividend of NT$2.99 per shareEligible shareholders must have bought the stock before 27 September 2022. Payment date: 21 October 2022. Payout ratio is on the higher end at 95% but the company is not cash flow positive. Trailing yield: 6.2%. Lower than top quartile of Taiwanese dividend payers (6.7%). Lower than average of industry peers (8.1%).
Buying Opportunity • Aug 20Now 20% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be NT$57.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13%.
Reported Earnings • Aug 15Second quarter 2022 earnings released: EPS: NT$1.24 (vs NT$2.34 in 2Q 2021)Second quarter 2022 results: EPS: NT$1.24 (down from NT$2.34 in 2Q 2021). Revenue: NT$793.3m (up 41% from 2Q 2021). Net income: NT$106.9m (down 47% from 2Q 2021). Profit margin: 14% (down from 36% in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.
Reported Earnings • May 16First quarter 2022 earnings released: EPS: NT$1.06 (vs NT$0.67 in 1Q 2021)First quarter 2022 results: EPS: NT$1.06 (up from NT$0.67 in 1Q 2021). Revenue: NT$632.7m (up 20% from 1Q 2021). Net income: NT$91.0m (up 60% from 1Q 2021). Profit margin: 14% (up from 11% in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 18% per year.
Buying Opportunity • May 12Now 23% undervaluedOver the last 90 days, the stock is up 35%. The fair value is estimated to be NT$58.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.2% over the last 3 years. Earnings per share has grown by 10%.
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$49.15, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 100% over the past three years.
Valuation Update With 7 Day Price Move • Apr 12Investor sentiment improved over the past weekAfter last week's 20% share price gain to NT$53.90, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 125% over the past three years.
공시 • Apr 02Huikwang Corporation, Annual General Meeting, Jun 22, 2022Huikwang Corporation, Annual General Meeting, Jun 22, 2022.
Reported Earnings • Mar 31Full year 2021 earnings released: EPS: NT$3.85 (vs NT$2.22 in FY 2020)Full year 2021 results: EPS: NT$3.85 (up from NT$2.22 in FY 2020). Revenue: NT$2.09b (up 14% from FY 2020). Net income: NT$329.1m (up 74% from FY 2020). Profit margin: 16% (up from 10% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.
Valuation Update With 7 Day Price Move • Mar 28Investor sentiment improved over the past weekAfter last week's 26% share price gain to NT$44.30, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 84% over the past three years.
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS NT$0.39 (vs NT$0.39 in 3Q 2020)The company reported a mediocre third quarter result with weaker profit margins, although earnings were flat and revenues improved. Third quarter 2021 results: Revenue: NT$488.8m (up 26% from 3Q 2020). Net income: NT$33.3m (flat on 3Q 2020). Profit margin: 6.8% (down from 8.6% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year.
Valuation Update With 7 Day Price Move • Oct 19Investor sentiment improved over the past weekAfter last week's 22% share price gain to NT$39.30, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 81% over the past three years.
Upcoming Dividend • Aug 19Upcoming dividend of NT$1.59 per shareEligible shareholders must have bought the stock before 26 August 2021. Payment date: 17 September 2021. Trailing yield: 5.2%. Within top quartile of Taiwanese dividend payers (5.2%). Higher than average of industry peers (2.9%).
Reported Earnings • Aug 13Second quarter 2021 earnings released: EPS NT$2.34 (vs NT$0.71 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$562.9m (up 3.7% from 2Q 2020). Net income: NT$200.5m (up 230% from 2Q 2020). Profit margin: 36% (up from 11% in 2Q 2020). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 3% per year.
Reported Earnings • May 14First quarter 2021 earnings released: EPS NT$0.67 (vs NT$1.05 in 1Q 2020)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$525.5m (down 13% from 1Q 2020). Net income: NT$57.0m (down 36% from 1Q 2020). Profit margin: 11% (down from 15% in 1Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 4% per year.
분석 기사 • Mar 31Huikwang (GTSM:6508) Might Have The Makings Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • Mar 27Full year 2020 earnings released: EPS NT$2.22 (vs NT$2.67 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$1.84b (down 12% from FY 2019). Net income: NT$189.2m (down 16% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Mar 10New 90-day high: NT$31.00The company is up 1.0% from its price of NT$30.65 on 10 December 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
분석 기사 • Mar 10Huikwang Corporation (GTSM:6508) Is Yielding 5.9% - But Is It A Buy?Dividend paying stocks like Huikwang Corporation ( GTSM:6508 ) tend to be popular with investors, and for good reason...
분석 기사 • Feb 16Huikwang (GTSM:6508) Could Easily Take On More DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Jan 27Is Huikwang Corporation's (GTSM:6508) Latest Stock Performance Being Led By Its Strong Fundamentals?Most readers would already know that Huikwang's (GTSM:6508) stock increased by 3.3% over the past three months. Given...
분석 기사 • Jan 06Shareholders Of Huikwang (GTSM:6508) Must Be Happy With Their 65% ReturnWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...
분석 기사 • Dec 15Will the Promising Trends At Huikwang (GTSM:6508) Continue?What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Is New 90 Day High Low • Dec 09New 90-day high: NT$30.90The company is up 4.0% from its price of NT$29.60 on 11 September 2020. The Taiwanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
분석 기사 • Nov 27Is Huikwang Corporation (GTSM:6508) A Smart Choice For Dividend Investors?Could Huikwang Corporation (GTSM:6508) be an attractive dividend share to own for the long haul? Investors are often...
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS NT$0.39The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$387.5m (down 25% from 3Q 2019). Net income: NT$33.3m (down 44% from 3Q 2019). Profit margin: 8.6% (down from 11% in 3Q 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.